0.54
-0.1057(-16.47%)
Currency In USD
| Previous Close | 0.64 |
| Open | 0.64 |
| Day High | 0.67 |
| Day Low | 0.53 |
| 52-Week High | 3.92 |
| 52-Week Low | 0.43 |
| Volume | 596,414 |
| Average Volume | 608,395 |
| Market Cap | 5.21M |
| PE | -0.78 |
| EPS | -0.69 |
| Moving Average 50 Days | 0.82 |
| Moving Average 200 Days | 1.28 |
| Change | -0.11 |
If you invested $1000 in Bullfrog AI Holdings, Inc. Common Stock (BFRG) since IPO date, it would be worth $82.46 as of February 21, 2026 at a share price of $0.536. Whereas If you bought $1000 worth of Bullfrog AI Holdings, Inc. Common Stock (BFRG) shares 2 years ago, it would be worth $127.62 as of February 21, 2026 at a share price of $0.536.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BullFrog AI to Unveil New Precision AI Capability
GlobeNewswire Inc.
Feb 04, 2026 12:30 PM GMT
New capabilities to be launched on March 25Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly defining clinical trial strategies and building
BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
GlobeNewswire Inc.
Jan 27, 2026 12:30 PM GMT
White paper discusses how BullFrog AI’s bfPREP™ embodies data harmonization, enabling biopharma organizations to convert noisy, document-heavy data into standardized, AI-ready datasetsGAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
GlobeNewswire Inc.
Jan 06, 2026 12:30 PM GMT
Company’s bfLEAP® platform successfully identified treatment effect heterogeneity and possible early predictors of outcomes in pancreatic cancer in data to be presented at ASCO GIGAITHERSBURG, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Hold